79
Views
6
CrossRef citations to date
0
Altmetric
Urology

Radiofrequency ablation in kidney tumour management: A method of real-time monitoring

, &
Pages 84-90 | Received 12 Nov 2009, Accepted 11 Dec 2009, Published online: 22 Jan 2010

References

  • Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Cancer statistics, 2008. CA Cancer J Clin 2008;58:71–96.
  • Van Poppel H, Dilen K, Baert L. Incidental renal cell carcinoma and nephron sparing surgery. Curr Opin Urol 2001;11:281–6.
  • Berger A, Crouzet S, Canes D, Haber GP, Gill IS. Minimally invasive nephron-sparing surgery. Curr Opin Urol 2008;18:462–6.
  • Su LM, Jarrett TW, Chan DY, Kavoussi LR, Solomon SB. Percutaneous computed tomography-guided radiofrequency ablation of renal masses in high surgical risk patients: preliminary results. Urology 2003;61:26–33.
  • Carrafiello G, Lagana D, Ianniello A, Mangini M, Fontana F, Cotta E, Percutaneous radiofrequency thermal ablation of renal cell carcinoma: is it possible a day-hospital treatment? Int J Surg 2008;6 Suppl 1:S31–5.
  • Pandharipande PV, Gervais DA, Mueller PR, Hur C, Gazelle GS. Radiofrequency ablation versus nephron-sparing surgery for small unilateral renal cell carcinoma: cost-effectiveness analysis. Radiology 2008;248:169–78.
  • Zlotta AR, Wildschutz T, Raviv G, Peny MO, van Gansbeke D, Noel JC, Radiofrequency interstitial tumor ablation (RITA) is a possible new modality for treatment of renal cancer: ex vivo and in vivo experience. J Endourol 1997;11:251–8.
  • Klingler HC, Marberger M, Mauermann J, Remzi M, Susani M. “Skipping” is still a problem with radiofrequency ablation of small renal tumours. BJU Int 2007;99:998–1001.
  • Michaels MJ, Rhee HK, Mourtzinos AP, Summerhayes IC, Silverman ML, Libertino JA. Incomplete renal tumor destruction using radio frequency interstitial ablation. J Urol 2002;168:2406–9.
  • Goldberg SN, Gazelle GS. Radiofrequency tissue ablation: physical principles and techniques for increasing coagulation necrosis. Hepatogastroenterology 2001;48:359–67.
  • Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR. Radiofrequency ablation of renal cell carcinoma: Part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am J Roentgenol 2005;185:64–71.
  • Kutikov A, Uzzo RG. The RENAL nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol 2009;182:844–53.
  • Klatte T, Patard JJ, de Martino M, Bensalah K, Verhoest G, de la Taille A, Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas. J Urol 2008;179:1719–26.
  • Volpe A, Panzarella T, Rendon RA, Haider MA, Kondylis FI, Jewett MA. The natural history of incidentally detected small renal masses. Cancer 2004;100:738–45.
  • Salagierski M, Salagierski M, Salagierska-Barwinska A, Sosnowski M. Percutaneous ultrasound-guided radiofrequency ablation for kidney tumors in patients with surgical risk. Int J Urol 2006;13:1375–9.
  • Zagoria RJ, Traver MA, Werle DM, Perini M, Hayasaka S, Clark PE. Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas. AJR Am J Roentgenol 2007;189:429–36.
  • Veltri A, Calvo A, Tosetti I, Pagano E, Genovesio A, Virzi V, Experiences in US-guided percutaneous radiofrequency ablation of 44 renal tumors in 31 patients: analysis of predictors for complications and technical success. Cardiovasc Intervent Radiol 2006;29:811–8.
  • Carey RI, Leveillee RJ. First prize: direct real-time temperature monitoring for laparoscopic and CT-guided radiofrequency ablation of renal tumors between 3 and 5 cm. J Endourol 2007;21:807–13.
  • Boss A, Rempp H, Martirosian P, Clasen S, Schraml C, Stenzl A, Wide-bore 1.5 Tesla MR imagers for guidance and monitoring of radiofrequency ablation of renal cell carcinoma: initial experience on feasibility. Eur Radiol 2008;18:1449–55.
  • Ukimura O, Mitterberger M, Okihara K, Miki T, Pinggera GM, Neururer R, Real-time virtual ultrasonographic radiofrequency ablation of renal cell carcinoma. BJU Int 2008;101:707–11.
  • Johnson DB, Duchene DA, Taylor GD, Pearle MS, Cadeddu JA. Contrast-enhanced ultrasound evaluation of radiofrequency ablation of the kidney: reliable imaging of the thermolesion. J Endourol 2005;19:248–52.
  • Park BK, Kim CK. Complications of image-guided radiofrequency ablation of renal cell carcinoma: causes, imaging features and prevention methods. Eur Radiol 2009;19:2180–90.
  • Carrafiello G, Lagana D, Ianniello A, Dionigi G, Novario R, Recaldini C, Post-radiofrequency ablation syndrome after percutaneous radiofrequency of abdominal tumours: one centre experience and review of published works. Australas Radiol 2007;51:550–4.
  • Anderson JK, Baker M, Jaffers O, Pearle MS, Lindberg GL, Cadeddu JA. Time course of nicotinamide adenine dinucleotide diaphorase staining after renal radiofrequency ablation influences viability assessment. J Endourol 2007;21:223–7.
  • Stern JM, Anderson JK, Lotan Y, Park S, Cadeddu JA. Nicotinamide adenine dinucleotide staining immediately following radio frequency ablation of renal tumors – is a positive stain synonymous with ablative failure? J Urol 2006;176:1969–72.
  • Dechet CB, Zincke H, Sebo TJ, King BF, LeRoy AJ, Farrow GM, Prospective analysis of computerized tomography and needle biopsy with permanent sectioning to determine the nature of solid renal masses in adults. J Urol 2003;169:71–4.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.